San Francisco-based startup Mave Health has announced a $495 neuromodulation headset designed to enhance attention, regulate stress, and improve mood without requiring medical clearance. The wearable targets issues like depression, anxiety, and insomnia by applying brain-stimulating signals. Co-founded by Dhawal Jain, Jai Sharma, and Aman Kumar, the company aims to provide users with a non-invasive solution for mental wellness.
Following personal experiences during the COVID-19 pandemic, where traditional mental health approaches seemed lacking, the founders sought to create a device that could offer tangible measurements of progress in mental health treatment. By leveraging neuroscience and neuromodulation techniques, Mave Health’s headset represents a consumer-focused application of technology that has primarily been confined to research labs.
With pre-orders now open at $495, Mave Health plans to start shipping devices to customers in the U.S. and India by April 2026. The company’s approach to mental health and mood enhancement signifies a shift towards accessible tech solutions for personal well-being.
Source: TechCrunch